Dose Booster anti COVID-19 (primo richiamo): quando farla?
Moderna on X: "Today, we shared positive pre-clinical data demonstrating our ability to combine 6 mRNAs against 3 different respiratory viruses in 1 vaccine: COVID-19 booster + Flu booster + RSV booster. #
SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination | NEJM
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant - ScienceDirect
Boosting with variant-matched vaccines: an opportunity to win the race against Omicron | Signal Transduction and Targeted Therapy
Interim statement on the use of additional booster doses of Emergency Use Listed mRNA vaccines against COVID-19 - PAHO/WHO | Pan American Health Organization
Chinese mRNA COVID booster stronger against Omicron than Sinovac shot -trial data | Reuters
Boosting with updated COVID-19 mRNA vaccines | Nature Medicine
COVID-19 mRNA booster provides additional protection, most beneficial for older adults
U.K. study finds mRNA COVID-19 vaccines provide biggest booster impact | CBC News
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...
CDC - CDC recommends Novavax's non-mRNA booster for people... | Facebook
Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study - The Lancet Infectious Diseases
Data suggests mRNA booster dose generates stronger antibody response after J&J shot - Axios | Reuters
Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status — United States, January 12, 2022–March 28, 2022 | MMWR
Vaccines | Free Full-Text | Immunogenicity against the Omicron Variant after mRNA-Based COVID-19 Booster Vaccination in Medical Students Who Received Two Primary Doses of the mRNA-1273 Vaccine
Association Between mRNA Vaccination and Infection From SARS-CoV-2 During the Delta and Omicron BA.1 Waves: A Population-Level Analysis - AJPM Focus
CDC - UPDATED: CDC updated booster recommendations for... | Facebook
Real-world data study confirms bivalent mRNA booster vaccines associated with greater short-term protection
A Booster mRNA Vaccine Required to Protect Against Omicron Variant
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
Study: Booster dose of mRNA COVID vaccine prompts strong T cell response in immunocompromised patients
Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged ≥18 years: a randomised, double-blind, phase 2b trial - The Lancet
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
Three mRNA COVID-19 vaccine doses very effective in protecting against emergency department visits and hospitalizations associated with Omicron and Delta variants
Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine: a prospective and retrospective cohort study - The Lancet Respiratory Medicine
India-made mRNA vaccine priced at ₹2,292, will be available as a booster dose - The Hindu
